Tdap booster vaccine candidate
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Tdap booster vaccine candidate, covering 2016-09-15 to 2016-09-15. Get the full timeline:
Most recent: Clinical Trial Update: Assessment of GSK Biologicals' Tdap Candidate Vaccine Administered as a Booster (6th Dose) in Terms of Immunogenicity and Safety to Children and Adolescents Previously Vaccinated With Five Doses of an Acellular Pertussis-containing Vaccine. [Phase 3]